Abstract
Pentagalloyl glucose (PGG) is an elastin-stabilizing polyphenolic compound that has significant biomedical benefits, such as being a free radical sink, an anti-inflammatory agent, anti-diabetic agent, enzymatic resistant properties, etc. This review article focuses on the important benefits of PGG on vascular health, including its role in tissue mechanics, the different modes of pharmacological administration (e.g., oral, intravenous and endovascular route, intraperitoneal route, subcutaneous route, and nanoparticle based delivery and microbubble-based delivery), and its potential therapeutic role in vascular diseases such as abdominal aortic aneurysms (AAA). In particular, the use of PGG for AAA suppression and prevention has been demonstrated to be effective only in the calcium chloride rat AAA model. Therefore, in this critical review we address the challenges that lie ahead for the clinical translation of PGG as an AAA growth suppressor.
Similar content being viewed by others
Abbreviations
- 60Co-γ rays:
-
Cobalt-60 gamma rays
- 6-Keto-PGF1α:
-
6-Keto-prostaglandin 1α
- ADP:
-
Adenosine-5′-diphosphate
- ALT:
-
Alanine aminotransferase
- AP-1:
-
Activator protein-1
- ArA:
-
Arachidonic acid
- B16F10:
-
Metastatic mouse melanoma cells
- BHK-21 cells:
-
Baby hamster kidney cell
- BV-2:
-
Transfected microglial cell line
- CAT:
-
Catalase
- CC50 :
-
50% cytotoxic concentration
- Cmax :
-
Maximum serum concentration that a drug achieves in a test area of the body after the drug has been administrated and before the administration of a second dose
- CML cell line K56:
-
Human chronic myelogenous leukemia
- DMSO:
-
Dimethylsulfoxide
- DPPH:
-
2,2-diphenyl-1-picrylhydrazyl
- EC 2.3.1.67:
-
Acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase
- EC50 :
-
The concentration of a compound where 50% of its maximal effect is observed
- EGF:
-
Epidermal growth factor
- FcɛRI:
-
High-affinity IgE receptors
- GPIIb/IIIa:
-
Glycoprotein IIb/IIIa inhibitors
- GSH-Px:
-
Glutathione peroxidase
- HBZY-1 cells:
-
Glomerular mesangial cell line
- HPBMC:
-
Human peripheral blood mononuclear cells
- HUVECs:
-
Human umbilical vein endothelial cells
- IB5:
-
Basic salivary protein
- IC50 :
-
Half maximal inhibitory concentration
- ICAM-1:
-
Intercellular adhesion molecule 1
- IL-1:
-
Interleukin-1
- IL-4:
-
Interleukin-4
- IL-6:
-
Interleukin-6
- IL-8:
-
Interleukin-8
- IL-10:
-
Interleukin-10
- Kd :
-
Dissociation constant—represents ligand-receptor affinity
- mBMMCs:
-
Mouse bone marrow-derived mast cells
- MCP-1:
-
Monocyte chemoattractant protein 1
- NF-kB:
-
Nuclear factor-kB
- NO-cGMP pathway:
-
Nitric oxide/cyclic guanosine monophosphate signaling pathway
- NOS:
-
Nitric oxide synthase
- NR:
-
Not reported
- NS3:
-
Nonstructural protein 3
- PAF:
-
1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine
- PC-3:
-
Human prostate cancer cell line
- PMN:
-
Polymorphonuclear leukocyte system
- rhALR2:
-
Recombinant human aldose reductase
- ROS:
-
Reactive oxygen species
- SCID:
-
Severe combined immunodeficiency
- SK-MEL-28:
-
Human skin melanoma cell line
- SOD:
-
Superoxide dismutase
- SP-1:
-
Specificity protein 1
- TGF-β1:
-
Transforming growth factor beta 1
- Tmax :
-
Time at which the Cmax is observed
- TNF-α:
-
Tumor necrosis factor alpha
- TXB2:
-
Thromboxane B2
- U937:
-
(Pro-) monocytic cell lines
- V79-4 cells:
-
Chinese hamster lung fibroblasts
- XOD:
-
Xanthine oxidase
References
Abdel-Mageed, W. M., S. A. Bayoumi, C. Chen, C. J. Vavricka, L. Li, A. Malik, H. Dai, F. Song, L. Wang, J. Zhang, G. F. Gao, Y. Lv, L. Liu, X. Liu, H. M. Sayed, and L. Zhang. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity. Bioorgan. Med. Chem. 22:2236–2243, 2014.
Abdelwahed, A., I. Bouhlel, I. Skandrani, K. Valenti, M. Kadri, P. Guiraud, R. Steiman, A. M. Mariotte, K. Ghedira, F. Laporte, M. G. Dijoux-Franca, and L. Chekir-Ghedira. Study of antimutagenic and antioxidant activities of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Confirmation by microarray expression profiling. Chem. Biol. Interact. 165:1–13, 2007.
Abdul-Hussien, H., R. Hanemaaijer, J. H. Verheijen, J. H. van Bockel, R. H. Geelkerken, and J. H. Lindeman. Doxycycline therapy for abdominal aneurysm: improved proteolytic balance through reduced neutrophil content. J. Vasc. Surg. 49:741–749, 2009.
Adolph, R., D. A. Vorp, D. L. Steed, M. W. Webster, M. V. Kameneva, and S. C. Watkins. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J. Vasc. Surg. 25:916–926, 1997.
Allaire, E. Cyclosporine A in patients with small diameter abdominal aortic aneurysm. https://clinicaltrials.gov/show/NCT02225756, 2010.
Alkilani, A. Z., M. T. McCrudden, and R. F. Donnelly. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 7:438–470, 2015.
Appis, A. W., M. J. Tracy, and S. B. Feinstein. Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications. Echo Res. Pract. 2:R55–R62, 2015.
Bahadar, H., F. Maqbool, K. Niaz, and M. Abdollahi. Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed. J. 20:1–11, 2016.
Bajaj, G., and Y. Yeo. Drug delivery systems for intraperitoneal therapy. Pharm. Res. 27:735–738, 2010.
Barenholz, Y. Doxil(R)–the first FDA-approved nano-drug: lessons learned. J. Control Release 160:117–134, 2012.
Baxter, B. T., Curci, J., Matsumura, J., and Terrin, M. L. Non-invasive treatment of abdominal aortic aneurysm clinical trial. https://clinicaltrials.gov/show/NCT01756833, 2016.
Baxter, B. T., V. A. Davis, D. J. Minion, Y. P. Wang, T. G. Lynch, and B. M. McManus. Abdominal aortic aneurysms are associated with altered matrix proteins of the nonaneurysmal aortic segments. J. Vasc. Surg. 19:797–802, 1994; ((Discussion 803)).
Baxter, N. J., T. H. Lilley, E. Haslam, and M. P. Williamson. Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in complexation and precipitation. Biochemistry 36:5566–5577, 1997.
Behrendt, P., P. Perin, N. Menzel, D. Banda, S. Pfaender, M. P. Alves, V. Thiel, P. Meuleman, C. C. Colpitts, L. M. Schang, F. W. R. Vondran, Anggakusuma, M. P. Manns, E. Steinmann, and T. Pietschmann. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. Antivir. Res. 147:19–28, 2017.
Bennick, A. Interaction of plant polyphenols with salivary proteins. Crit. Rev. Oral Biol. Med. 13:184–196, 2002.
Bhimani, R. S., W. Troll, D. Grunberger, and K. Frenkel. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res. 53:4528–4533, 1993.
Bicknell, C. D., G. Kiru, E. Falaschetti, J. T. Powell, N. R. Poulter, and A. Collaborators. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK). Eur. Heart J. 37:3213–3221, 2016.
Bing, S. J., M. J. Kim, E. Park, G. Ahn, D. S. Kim, R. K. Ko, N. H. Lee, T. Shin, J. W. Park, and Y. Jee. 1,2,3,4,6-penta-O-galloyl-beta-d-glucose protects splenocytes against radiation-induced apoptosis in murine splenocytes. Biol. Pharm. Bull. 33:1122–1127, 2010.
Blanchard, J. F., H. K. Armenian, and P. P. Friesen. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am. J. Epidemiol. 151:575–583, 2000.
Bors, W., L. Y. Foo, N. Hertkorn, C. Michel, and K. Stettmaier. Chemical studies of proanthocyanidins and hydrolyzable tannins. Antioxid. Redox Signal. 3:995–1008, 2001.
Cai, K., and A. Bennick. Effect of salivary proteins on the transport of tannin and quercetin across intestinal epithelial cells in culture. Biochem. Pharmacol. 72:974–980, 2006.
Cai, K., A. E. Hagerman, R. E. Minto, and A. Bennick. Decreased polyphenol transport across cultured intestinal cells by a salivary proline-rich protein. Biochem. Pharmacol. 71:1570–1580, 2006.
Cao, Y., K. B. Himmeldirk, Y. Qian, Y. Ren, A. Malki, and X. Chen. Biological and biomedical functions of penta-O-galloyl-d-glucose and its derivatives. J. Nat. Med. 68:465–472, 2014.
Carmo, M., L. Colombo, A. Bruno, F. R. M. Corsi, L. Roncoroni, M. S. Cuttin, F. Radice, E. Mussini, and P. G. Settembrini. Alteration of elastin, collagen and their cross-links in abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 23:543–549, 2002.
Chai, Y., H. J. Lee, A. A. Shaik, K. Nkhata, C. Xing, J. Zhang, S. J. Jeong, S. H. Kim, and J. Lu. Penta-O-galloyl-beta-d-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth. Breast Cancer Res. 12:R67, 2010.
Charlton, A. J., N. J. Baxter, M. L. Khan, A. J. Moir, E. Haslam, A. P. Davies, and M. P. Williamson. Polyphenol/peptide binding and precipitation. J. Agric. Food Chem. 50:1593–1601, 2002.
Charlton, A. J., N. J. Baxter, T. H. Lilley, E. Haslam, C. J. McDonald, and M. P. Williamson. Tannin interactions with a full-length human salivary proline-rich protein display a stronger affinity than with single proline-rich repeats. FEBS Lett. 382:289–292, 1996.
Chauhan, S. S., C. A. Gutierrez, M. Thirugnanasambandam, V. De Oliveira, S. C. Muluk, M. K. Eskandari, and E. A. Finol. The association between geometry and wall stress in emergently repaired abdominal aortic aneurysms. Ann. Biomed. Eng. 45:1908–1916, 2017.
Chen, Y., and A. E. Hagerman. Characterization of soluble non-covalent complexes between bovine serum albumin and beta-1,2,3,4,6-penta-O-galloyl-d-glucopyranose by MALDI-TOF MS. J. Agric. Food Chem. 52:4008–4011, 2004.
Chen, Y., and A. E. Hagerman. Reaction pH and protein affect the oxidation products of beta-pentagalloyl glucose. Free Rad. Res. 39:117–124, 2005.
Cheng, J.-T., and Hsu, F.-L. Tannin derivatives and their use for treatment of hypertension. https://www.google.com/patents/US5266319. Google Patents, 1993.
Chow, J. P., D. T. Simionescu, A. L. Carter, and A. Simionescu. Immunomodulatory effects of adipose tissue-derived stem cells on elastin scaffold remodeling in diabetes. Tissue Eng. Regen. Med. 13:701–712, 2016.
Chow, J. P., D. T. Simionescu, H. Warner, B. Wang, S. S. Patnaik, J. Liao, and A. Simionescu. Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol. Biomaterials 34:685–695, 2013.
Chu, A. Healthy Harvest, Hale Heart. J. Cardiovasc. Disord. 1:3, 2014. http://austinpublishinggroup.com/cardiovascular-disorders/fulltext/jcd-v1-id1004.pdf.
Chuang, T. H., C. Stabler, A. Simionescu, and D. T. Simionescu. Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng. A 15:2837–2851, 2009.
Cryan, L. M., L. Bazinet, K. A. Habeshian, S. Cao, J. Clardy, K. A. Christensen, and M. S. Rogers. 1,2,3,4,6-Penta-O-galloyl-beta-d-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2. J. Med. Chem. 56:1940–1945, 2013.
Daugherty, A., M. W. Manning, and L. A. Cassis. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105:1605–1612, 2000.
De Jong, W. H., and P. J. Borm. Drug delivery and nanoparticles:applications and hazards. Int. J. Nanomed. 3:133–149, 2008.
Deborde, C., D. T. Simionescu, C. Wright, J. Liao, L. N. Sierad, and A. Simionescu. Stabilized collagen and elastin-based scaffolds for mitral valve tissue engineering. Tissue Eng. A 22:1241–1251, 2016.
Dimcevski, G., S. Kotopoulis, T. Bjanes, D. Hoem, J. Schjott, B. T. Gjertsen, M. Biermann, A. Molven, H. Sorbye, E. McCormack, M. Postema, and O. H. Gilja. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J. Control Release 243:172–181, 2016.
Dobreva, M. A., R. A. Frazier, I. Mueller-Harvey, L. A. Clifton, A. Gea, and R. J. Green. Binding of pentagalloyl glucose to two globular proteins occurs via multiple surface sites. Biomacromolecules 12:710–715, 2011.
Dong, H., S. X. Chen, R. M. Kini, and H. X. Xu. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. J. Nat. Prod. 61:1356–1360, 1998.
Emeto, T. I., F. O. Alele, A. M. Smith, F. M. Smith, T. Dougan, and J. Golledge. Use of nanoparticles as contrast agents for the functional and molecular imaging of abdominal aortic aneurysm. Front. Cardiovasc. Med. 4:16, 2017.
Fajemiroye, J. O., K. Adam, K. Z. Jordan, C. E. Alves, and A. A. Aderoju. Evaluation of anxiolytic and antidepressant-like activity of aqueous leaf extract of Nymphaea Lotus Linn. in Mice. Iran J. Pharm. Res. 17:613–626, 2018.
Feinstein, S. B., J. Cheirif, F. J. Ten Cate, P. R. Silverman, P. A. Heidenreich, C. Dick, R. M. Desir, W. F. Armstrong, M. A. Quinones, and P. M. Shah. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J. Am. Coll. Cardiol. 16:316–324, 1990.
Feldman, K. S., K. Sahasrabudhe, M. D. Lawlor, S. L. Wilson, C. H. Lang, and W. J. Scheuchenzuber. In vitro and In vivo inhibition of LPS-stimulated tumor necrosis factor-alpha secretion by the gallotannin beta-d-pentagalloylglucose. Bioorgan. Med. Chem. Lett. 11:1813–1815, 2001.
Fercana, G., D. Bowser, M. Portilla, E. M. Langan, C. G. Carsten, D. L. Cull, L. N. Sierad, and D. T. Simionescu. Platform technologies for decellularization, tunic-specific cell seeding, and in vitro conditioning of extended length, small diameter vascular grafts. Tissue Eng. C 20:1016–1027, 2014.
Ferguson, C. D., P. Clancy, B. Bourke, P. J. Walker, A. Dear, T. Buckenham, P. Norman, and J. Golledge. Association of statin prescription with small abdominal aortic aneurysm progression. Am. Heart J. 159:307–313, 2010.
Geers, B., I. Lentacker, N. N. Sanders, J. Demeester, S. Meairs, and S. C. De Smedt. Self-assembled liposome-loaded microbubbles: the missing link for safe and efficient ultrasound triggered drug-delivery. J. Control Release 152:249–256, 2011.
Genfa, L., Z. Jiang, Z. Hong, Z. Yimin, W. Liangxi, W. Guo, H. Ming, J. Donglen, and W. Lizhao. The screening and isolation of an effective anti-endotoxin monomer from Radix Paeoniae Rubra using affinity biosensor technology. Int. Immunopharmacol. 5:1007–1017, 2005.
Gilabert, R., L. Bunesch, M. I. Real, A. Garcia-Criado, M. Burrel, J. R. Ayuso, M. Barrufet, X. Montana, and V. Riambau. Evaluation of abdominal aortic aneurysm after endovascular repair: prospective validation of contrast-enhanced US with a second-generation US contrast agent. Radiology 264:269–277, 2012.
Golledge, J., and P. E. Norman. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 217:57–63, 2011.
Golledge, J., P. E. Norman, M. P. Murphy, and R. L. Dalman. Challenges and opportunities in limiting abdominal aortic aneurysm growth. J. Vasc. Surg. 65:225–233, 2017.
Golledge, J., and J. T. Powell. Medical management of abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 34:267–273, 2007.
Goto, H., Y. Shimada, Y. Akechi, K. Kohta, M. Hattori, and K. Terasawa. Endothelium-dependent vasodilator effect of extract prepared from the roots of Paeonia lactiflora on isolated rat aorta. Planta Med. 62:436–439, 1996.
Gramiak, R., and P. M. Shah. Echocardiography of the aortic root. Invest. Radiol. 3:356–366, 1968.
Guessous, I., D. Periard, D. Lorenzetti, J. Cornuz, and W. A. Ghali. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis. PLoS ONE 3:e1895, 2008.
Gupta, A., D. Thompson, A. Whitehouse, T. Collier, B. Dahlof, N. Poulter, R. Collins, and P. Sever. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian cardiac outcomes trial—lipid-lowering arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet 389:2473–2481, 2017.
Gyemant, G., A. Zajacz, B. Becsi, C. Ragunath, N. Ramasubbu, F. Erdodi, G. Batta, and L. Kandra. Evidence for pentagalloyl glucose binding to human salivary alpha-amylase through aromatic amino acid residues. Biochim. Biophys. Acta 1794:291–296, 2009.
Hagerman, A. E., M. E. Rice, and N. T. Ritchard. Mechanisms of protein precipitation for two tannins, pentagalloyl glucose and epicatechin16(4 → 8) catechin (procyanidin). J. Agric. Food Chem. 46:2590–2595, 1998.
Heath, C. H., A. Sorace, J. Knowles, E. Rosenthal, and K. Hoyt. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo. Otolaryngol. Head Neck Surg. 146:938–945, 2012.
Ho, L.-L., W.-J. Chen, S.-Y. Lin-Shiau, and J.-K. Lin. Penta-O-galloyl-β-d-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol. 453:149–158, 2002.
Hoff, L., Sontum, P. C., and Hoff, B. Acoustic properties of shell-encapsulated, gas-filled ultrasound contrast agents. In: 1996 IEEE US Symp. IEEE, 1996, pp. 1441–1444.
Hofmann, T., A. Glabasnia, B. Schwarz, K. N. Wisman, K. A. Gangwer, and A. E. Hagerman. Protein binding and astringent taste of a polymeric procyanidin, 1,2,3,4,6-penta-O-galloyl-beta-d-glucopyranose, castalagin, and grandinin. J. Agric. Food Chem. 54:9503–9509, 2006.
Hofmann, T., E. Nebehaj, and L. Albert. Antioxidant properties and detailed polyphenol profiling of European hornbeam (Carpinus betulus L.) leaves by multiple antioxidant capacity assays and high-performance liquid chromatography/multistage electrospray mass spectrometry. Ind. Crops Prod. 87:340–349, 2016.
https://www.users.miamioh.edu/hagermae/Pentagalloyl%20Glucose.pdf, 2002.
Huh, J. E., E. O. Lee, M. S. Kim, K. S. Kang, C. H. Kim, B. C. Cha, Y. J. Surh, and S. H. Kim. Penta-O-galloyl-beta-d-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 26:1436–1445, 2005.
Isenburg, J. C., N. V. Karamchandani, D. T. Simionescu, and N. R. Vyavahare. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 27:3645–3651, 2006.
Isenburg, J. C., Ogle, M. F. Compositions for tissue stabilization. http://www.google.la/patents/US20160136109. Google Patents, 2016.
Isenburg, J. C., D. T. Simionescu, B. C. Starcher, and N. R. Vyavahare. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 115:1729–1737, 2007.
Isenburg, J. C., D. T. Simionescu, and N. R. Vyavahare. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials 25:3293–3302, 2004.
Isenburg, J. C., D. T. Simionescu, and N. R. Vyavahare. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials 26:1237–1245, 2005.
Isenburg, J. C., Vyavahare, N. R., Ogle, M. F. Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle. http://www.google.bs/patents/US20090214654. Google Patents, 2009.
Jablonowski, L. J., D. Conover, N. T. Teraphongphom, and M. A. Wheatley. Manipulating multifaceted microbubble shell composition to target both TRAIL-sensitive and resistant cells. J. Biomed. Mater. Res. A 106:1903–1915, 2018.
Jang, S. E., S. R. Hyam, J. J. Jeong, M. J. Han, and D. H. Kim. Penta-O-galloyl-beta-d-glucose ameliorates inflammation by inhibiting MyD88/NF-kappaB and MyD88/MAPK signalling pathways. Br. J. Pharmacol. 170:1078–1091, 2013.
Jeon, W. K., J. H. Lee, H. K. Kim, A. Y. Lee, S. O. Lee, Y. S. Kim, S. Y. Ryu, S. Y. Kim, Y. J. Lee, and B. S. Ko. Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua Stokes. J. Ethnopharmacol. 106:62–69, 2006.
Jiamboonsri, P., P. Pithayanukul, R. Bavovada, J. Leanpolchareanchai, T. Yin, S. Gao, and M. Hu. Factors influencing oral bioavailability of thai mango seed kernel extract and its key phenolic principles. Molecules 20:21254–21273, 2015.
Kageyama-Yahara, N., Y. Suehiro, F. Maeda, S. Kageyama, J. Fukuoka, T. Katagiri, T. Yamamoto, and M. Kadowaki. Pentagalloylglucose down-regulates mast cell surface FcepsilonRI expression in vitro and in vivo. FEBS Lett. 584:111–118, 2010.
Kang, D. G., M. K. Moon, D. H. Choi, J. K. Lee, T. O. Kwon, and H. S. Lee. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-d-glucose (PGG) via a nitric oxide-cGMP pathway. Eur. J. Pharmacol. 524:111–119, 2005.
Kanoh, R., T. Hatano, H. Ito, T. Yoshida, and M. Akagi. Effects of tannins and related polyphenols on superoxide-induced histamine release from rat peritoneal mast cells. Phytomedicine 7:297–302, 2000.
Karrowni, W., S. Dughman, G. P. Hajj, and F. J. Miller, Jr. Statin therapy reduces growth of abdominal aortic aneurysms. J. Invest. Med. 59:1239–1243, 2011.
Kim, W., R. T. Gandhi, C. S. Pena, R. E. Herrera, M. B. Schernthaner, J. M. Acuna, V. N. Becerra, and B. T. Katzen. Influence of statin therapy on aneurysm sac regression after endovascular aortic repair. J. Vasc. Interv. Radiol. 28:35–43, 2017.
Kim, S. J., S. A. Sancheti, S. S. Sancheti, B. H. Um, S. M. Yu, and S. Y. Seo. Effect of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose on elastase and hyaluronidase activities and its type II collagen expression. Acta Pol. Pharm. 67:145–150, 2010.
Kim, Y. H., M. Yoshimoto, K. Nakayama, S. Tanino, Y. Fujimura, K. Yamada, and H. Tachibana. Tannic acid, a higher galloylated pentagalloylglucose, suppresses antigen-specific IgE production by inhibiting varepsilon germline transcription induced by STAT6 activation. FEBS Open Bio. 3:341–345, 2013.
Kiss, A., B. Becsi, B. Kolozsvari, I. Komaromi, K. E. Kover, and F. Erdodi. Epigallocatechin-3-gallate and penta-O-galloyl-beta-d-glucose inhibit protein phosphatase-1. FEBS J. 280:612–626, 2013.
Kiss, A. K., A. Filipek, B. Zyzynska-Granica, and M. Naruszewicz. Effects of penta-O-galloyl-beta-d-glucose on human neutrophil function: significant down-regulation of L-selectin expression. Phytother. Res. 27:986–992, 2013.
Klibanov, A. L. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjug. Chem. 16:9–17, 2005.
Kloster, B. O., L. Lund, and J. S. Lindholt. Inhibition of early AAA formation by aortic intraluminal pentagalloyl glucose (PGG) infusion in a novel porcine AAA model. Ann. Med. Surg. 7:65–70, 2016.
Kooiman, K., H. J. Vos, M. Versluis, and N. de Jong. Acoustic behavior of microbubbles and implications for drug delivery. Adv. Drug Deliv. Rev. 72:28–48, 2014.
Krook, M. A., and A. E. Hagerman. Stability of polyphenols epigallocatechin gallate and pentagalloyl glucose in a simulated digestive system. Food Res. Int. 49:112–116, 2012.
Kuo, P. T., T. P. Lin, L. C. Liu, C. H. Huang, J. K. Lin, J. Y. Kao, and T. D. Way. Penta-O-galloyl-beta-d-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression. J. Agric. Food Chem. 57:3331–3339, 2009.
Larrosa, M., M. T. Garcia-Conesa, J. C. Espin, and F. A. Tomas-Barberan. Ellagitannins, ellagic acid and vascular health. Mol. Aspects Med. 31:513–539, 2010.
Lederle, F. A., G. R. Johnson, S. E. Wilson, E. P. Chute, F. N. Littooy, D. Bandyk, W. C. Krupski, G. W. Barone, C. W. Acher, and D. J. Ballard. Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann. Intern. Med. 126:441, 1997.
Lee, H. J., N. J. Seo, S. J. Jeong, Y. Park, D. B. Jung, W. Koh, H. J. Lee, E. O. Lee, K. S. Ahn, K. S. Ahn, J. Lu, and S. H. Kim. Oral administration of penta-O-galloyl-beta-d-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. Carcinogenesis 32:804–811, 2011.
Lee, E. H., D. G. Song, J. Y. Lee, C. H. Pan, B. H. Um, and S. H. Jung. Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull. 31:1626–1630, 2008.
Lentacker, I., S. C. De Smedt, and N. N. Sanders. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 5:2161–2170, 2009.
Li, L., A. A. Shaik, J. Zhang, K. Nhkata, L. Wang, Y. Zhang, C. Xing, S. H. Kim, and J. Lu. Preparation of penta-O-galloyl-beta-d-glucose from tannic acid and plasma pharmacokinetic analyses by liquid-liquid extraction and reverse-phase HPLC. J. Pharm. Biomed. Anal. 54:545–550, 2011.
Lin, T. C., F. L. Hsu, and J. T. Cheng. Antihypertensive activity of corilagin and chebulinic acid, tannins from lumnitzera-racemosa. J. Nat. Prod. 56:629–632, 1993.
Lindeman, J. H., B. A. Ashcroft, J. W. Beenakker, M. van Es, N. B. Koekkoek, F. A. Prins, J. F. Tielemans, H. Abdul-Hussien, R. A. Bank, and T. H. Oosterkamp. Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome. Proc. Natl. Acad. Sci. USA 107:862–865, 2010.
Liu, J. C., F. L. Hsu, J. C. Tsai, P. Chan, J. Y. Liu, G. N. Thomas, B. Tomlinson, M. Y. Lo, and J. Y. Lin. Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme. Life Sci. 73:1543–1555, 2003.
Lopez-de-Andres, A., I. Jimenez-Trujillo, R. Jimenez-Garcia, V. Hernandez-Barrera, J. M. de Miguel-Yanes, M. Mendez-Bailon, N. Perez-Farinos, M. A. Salinero-Fort, and P. Carrasco-Garrido. National trends in incidence and outcomes of abdominal aortic aneurysm among elderly type 2 diabetic and non-diabetic patients in Spain (2003–2012). Cardiovasc. Diabetol. 14:48, 2015.
Ma, C. X., X. Zhao, P. Wang, P. Jia, X. F. Zhao, C. N. Xiao, and X. H. Zheng. Metabolite characterization of penta-O-galloyl-beta-d-glucose in rat biofluids by HPLC-QTOF-MS. Chin. Herb. Med. 10:73–79, 2018.
Manach, C., A. Scalbert, C. Morand, C. Remesy, and L. Jimenez. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79:727–747, 2004.
Mao, X., C. Gu, D. Chen, B. Yu, and J. He. Oxidative stress-induced diseases and tea polyphenols. Oncotarget 8:81649–81661, 2017.
Martufi, G., E. S. Di Martino, C. H. Amon, S. C. Muluk, and E. A. Finol. Three-dimensional geometrical characterization of abdominal aortic aneurysms: image-based wall thickness distribution. J. Biomech. Eng. 131:061015, 2009.
Meijer, C. A., T. Stijnen, M. N. Wasser, J. F. Hamming, J. H. van Bockel, J. H. Lindeman, and G. Pharmaceutical Aneurysm Stabilisation Trial Study. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann. Intern. Med. 159:815–823, 2013.
Mendonca, P., E. Taka, D. Bauer, M. Cobourne-Duval, and K. F. Soliman. The attenuating effects of 1,2,3,4,6 penta-O-galloyl-beta-d-glucose on inflammatory cytokines release from activated BV-2 microglial cells. J. Neuroimmunol. 305:9–15, 2017.
Mercuri, J. J., S. Patnaik, G. Dion, S. S. Gill, J. Liao, and D. T. Simionescu. Regenerative potential of decellularized porcine nucleus pulposus hydrogel scaffolds: stem cell differentiation, matrix remodeling, and biocompatibility studies. Tissue Eng. A 19:952–966, 2013.
Miyake, T., and R. Morishita. Pharmacological treatment of abdominal aortic aneurysm. Cardiovasc. Res. 83:436–443, 2009.
Mohamed, F., P. Marchettini, O. A. Stuart, and P. H. Sugarbaker. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Cancer Chemother. Pharmacol. 52:405–410, 2003.
Mohan, C. G., G. L. Viswanatha, G. Savinay, C. E. Rajendra, and P. D. Halemani. 1,2,3,4,6 penta-O-galloyl-beta-d-glucose, a bioactivity guided isolated compound from Mangifera indica inhibits 11beta-HSD-1 and ameliorates high fat diet-induced diabetes in C57BL/6 mice. Phytomedicine 20:417–426, 2013.
Moran, C. S., S. W. Seto, S. M. Krishna, S. Sharma, R. J. Jose, E. Biros, Y. Wang, S. K. Morton, and J. Golledge. Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis. Sci. Rep. 7:43079, 2017.
Moris, D., E. Mantonakis, E. Avgerinos, M. Makris, C. Bakoyiannis, E. Pikoulis, and S. Georgopoulos. Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptions. BioMed Res. Int. 2014:925840, 2014.
Moro, F., I. De Blasis, B. Virgilio, A. Di Legge, G. Rindi, L. Bonomo, M. Storto, and A. C. Testa. P27.02: first in human study using KDR-targeted microbubbles (BR55) ultrasound molecular imaging in ovarian masses. Ultrasound Obstet. Gynecol. 48:255, 2016.
Mosorin, M., J. Juvonen, F. Biancari, J. Satta, H. M. Surcel, M. Leinonen, P. Saikku, and T. Juvonen. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J. Vasc. Surg. 34:606–610, 2001.
Murphy, M. P. Safety and efficacy of allogeneic MSCs in promoting T-regulatory cells in patients with small abdominal aortic aneurysms. http://www.clinicaltrial.co/ShowTrial/NCT02846883, 2016.
Nesbitt, W. S., E. Westein, F. J. Tovar-Lopez, E. Tolouei, A. Mitchell, J. Fu, J. Carberry, A. Fouras, and S. P. Jackson. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat. Med. 15:665–673, 2009.
Neveu, V., J. Perez-Jimenez, F. Vos, V. Crespy, L. du Chaffaut, L. Mennen, C. Knox, R. Eisner, J. Cruz, D. Wishart, and A. Scalbert. Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database 2010:bap024, 2010.
Nosoudi, N., A. Chowdhury, S. Siclari, S. Karamched, V. Parasaram, J. Parrish, P. Gerard, and N. Vyavahare. Reversal of vascular calcification and aneurysms in a rat model using dual targeted therapy with EDTA- and PGG-loaded nanoparticles. Theranostics 6:1975–1987, 2016.
Nosoudi, N., A. Chowdhury, S. Siclari, V. Parasaram, S. Karamched, and N. Vyavahare. Systemic delivery of nanoparticles loaded with pentagalloyl glucose protects elastic lamina and prevents abdominal aortic aneurysm in rats. J. Cardiovasc. Transl. Res. 9:445–455, 2016.
Oh, G. S., H. O. Pae, B. M. Choi, H. S. Lee, I. K. Kim, Y. G. Yun, J. D. Kim, and H. T. Chung. Penta-O-galloyl-beta-d-glucose inhibits phorbol myristate acetate-induced interleukin-8 [correction of intereukin-8] gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB. Int. Immunopharmacol. 4:377–386, 2004.
Paefgen, V., D. Doleschel, and F. Kiessling. Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front. Pharmacol. 6:197, 2015.
Pan, M. H., S. Y. Lin-Shiau, C. T. Ho, J. H. Lin, and J. K. Lin. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem. Pharmacol. 59:357–367, 2000.
Parasaram, V., N. Nosoudi, A. Chowdhury, and N. Vyavahare. Pentagalloyl glucose increases elastin deposition, decreases reactive oxygen species and matrix metalloproteinase activity in pulmonary fibroblasts under inflammatory conditions. Biochem. Biophys. Res. Commun. 499:24–29, 2018.
Parikh, S. A., R. Gomez, M. Thirugnanasambandam, S. S. Chauhan, V. De Oliveira, S. C. Muluk, M. K. Eskandari, and E. V. Finol. Decision tree based classification of abdominal aortic aneurysms using geometry quantification measures. Ann. Biomed. Eng. 2018. https://doi.org/10.1007/s10439-018-02116-w.
Park, J. K., H. J. Cho, Y. Lim, Y. H. Cho, and C. H. Lee. Hypocholestrolemic effect of CJ90002 in hamsters: a potent inhibitor for squalene synthase from Paeonia moutan. J. Microbiol. Biotechnol. 12:222–227, 2002.
Park, E., N. H. Lee, J. S. Baik, and Y. Jee. Elaeocarpus sylvestris modulates gamma-ray-induced immunosuppression in mice: implications in radioprotection. Phytother. Res. 22:1046–1051, 2008.
Parkinson, F., S. Ferguson, P. Lewis, I. M. Williams, C. P. Twine, and N South East Wales Vascular. Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair. J. Vasc. Surg. 61:1606–1612, 2015.
Pennel, T., G. Fercana, D. Bezuidenhout, A. Simionescu, T. H. Chuang, P. Zilla, and D. Simionescu. The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models. Biomaterials 35:6311–6322, 2014.
Phillips, E. H., A. A. Yrineo, H. D. Schroeder, K. E. Wilson, J. X. Cheng, and C. J. Goergen. Morphological and biomechanical differences in the elastase and AngII apoE(−/−) rodent models of abdominal aortic aneurysms. BioMed Res. Int. 2015:413189, 2015.
Piao, M. J., K. A. Kang, R. Zhang, D. O. Ko, Z. H. Wang, K. H. Lee, W. Y. Chang, S. Chae, Y. Jee, T. Shin, J. W. Park, N. H. Lee, and J. W. Hyun. Antioxidant properties of 1,2,3,4,6-penta-O-galloyl-β-d-glucose from Elaeocarpus sylvestris var. ellipticus. Food Chem. 115:412–418, 2009.
Pintea, A., D. Rugină, and Z. Diaconeasa. 4-Pharmacologically active plant-derived natural products. In: Smart Nanoparticles for Biomedicine, edited by G. Ciofani. Amsterdam: Elsevier, 2018, pp. 49–64.
Pitt, W. G., G. A. Husseini, and B. J. Staples. Ultrasonic drug delivery—a general review. Exp. Opin. Drug Deliv. 1:37–56, 2004.
Prall, A. K., G. M. Longo, W. G. Mayhan, E. A. Waltke, B. Fleckten, R. W. Thompson, and B. T. Baxter. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J. Vasc. Surg. 35:923–929, 2002.
Rader, D. J. High-density lipoproteins and atherosclerosis. Am. J. Cardiol. 90:62i–70i, 2002.
Ragheb, A. O., Ruane, P. H., and Biggs, D. P. Delivery of elastin-stabilizing compound within a body lumen. https://www.google.com/patents/WO2007133479A2?cl=en. Google Patents, 2007.
Ramakrishnan, S., K. Dharmalingam, S. T. Panchanatham, and S. Palanivelu. Efficacy of tridham and 1,2,3,4,6-penta-O-galloyl-β-d-glucose in reversing lipid peroxidation levels and mitochondrial antioxidant status in 7,12-dimethylbenzeneanthracene (Dmba) induced breast cancer in Sprague–Dawley rats. Int. J. Pharm. Pharm. Sci. 8:288, 2016.
Ramaswamy, A. K., M. Hamilton, 2nd, R. V. Joshi, B. P. Kline, R. Li, P. Wang, and C. J. Goergen. Molecular imaging of experimental abdominal aortic aneurysms. Sci. World J. 2013:973150, 2013.
Raut, S., S. Chandra, J. Shum, C. B. Washington, S. C. Muluk, E. A. Finol, and J. F. Rodriguez. Biological, geometric and biomechanical factors influencing abdominal aortic aneurysm rupture risk: a comprehensive review. Recent Patents Med. Imaging 3:44–59, 2013.
Ren, Y., and X. Chen. Distribution, bioactivities and therapeutical potentials of pentagalloylglucopyranose. Curr. Bioact. Compd. 3:81–89, 2007.
Ren, Y., K. Himmeldirk, and X. Chen. Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-d-glucopyranose and its analogues. J. Med. Chem. 49:2829–2837, 2006.
Ruggeri, Z. M., J. N. Orje, R. Habermann, A. B. Federici, and A. J. Reininger. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 108:1903–1910, 2006.
Ryan, S. M., G. Mantovani, X. Wang, D. M. Haddleton, and D. J. Brayden. Advances in PEGylation of important biotech molecules: delivery aspects. Exp. Opin. Drug Deliv. 5:371–383, 2008.
Safar, M. E., B. I. Levy, and H. Struijker-Boudier. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107:2864–2869, 2003.
Salata, K., M. Syed, M. Hussain, N. Alsaif, S. Verma, and M. Al-Omran. The impact of statins on abdominal aortic aneurysm growth, rupture, and perioperative outcomes: a systematic review and meta-analysis. J. Vasc. Surg. 66:E66–E67, 2017.
Sanna, V., G. Lubinu, P. Madau, N. Pala, S. Nurra, A. Mariani, and M. Sechi. Polymeric nanoparticles encapsulating white tea extract for nutraceutical application. J. Agric. Food Chem. 63:2026–2032, 2015.
Sanna, V., A. M. Roggio, A. M. Posadino, A. Cossu, S. Marceddu, A. Mariani, V. Alzari, S. Uzzau, G. Pintus, and M. Sechi. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies. Nanoscale Res. Lett. 6:260, 2011.
Schriefl, A. J., G. Zeindlinger, D. M. Pierce, P. Regitnig, and G. A. Holzapfel. Determination of the layer-specific distributed collagen fibre orientations in human thoracic and abdominal aortas and common iliac arteries. J. R. Soc. Interface 9:1275–1286, 2012.
Schroff, P., C. M. Gamboa, R. W. Durant, A. Oikeh, J. S. Richman, and M. M. Safford. Vulnerabilities to Health disparities and statin use in the REGARDS (reasons for geographic and racial differences in stroke) study. J. Am. Heart Assoc. 6:e005449, 2017.
Shavandi, A., A. E. A. Bekhit, P. Saeedi, Z. Izadifar, A. A. Bekhit, and A. Khademhosseini. Polyphenol uses in biomaterials engineering. Biomaterials 167:91–106, 2018.
Shen, A. M. Subcutaneous delivery of protein therapeutics https://search.proquest.com/docview/2003275315. Rutgers University-Graduate School-New Brunswick, 2017.
Shimada, T. Salivary proteins as a defense against dietary tannins. J. Chem. Ecol. 32:1149–1163, 2006.
Shum, J., G. Martufi, E. Di Martino, C. B. Washington, J. Grisafi, S. C. Muluk, and E. A. Finol. Quantitative assessment of abdominal aortic aneurysm geometry. Ann. Biomed. Eng. 39:277–286, 2011.
Sierad, L. N., A. Simionescu, C. Albers, J. Chen, J. Maivelett, M. E. Tedder, J. Liao, and D. T. Simionescu. Design and testing of a pulsatile conditioning system for dynamic endothelialization of polyphenol-stabilized tissue engineered heart valves. Cardiovasc. Eng. Technol. 1:138–153, 2010.
Sillesen, H., N. Eldrup, R. Hultgren, J. Lindeman, K. Bredahl, M. Thompson, A. Wanhainen, U. Wingren, J. Swedenborg, and A. T. Investigators. Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br. J. Surg. 102:894–901, 2015.
Sinha, A., N. Nosoudi, and N. Vyavahare. Elasto-regenerative properties of polyphenols. Biochem. Biophys. Res. Commun. 444:205–211, 2014.
Sinha, A., A. Shaporev, N. Nosoudi, Y. Lei, A. Vertegel, S. Lessner, and N. Vyavahare. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine 10:1003–1012, 2014.
Sirsi, S., and M. Borden. Microbubble compositions, properties and biomedical applications. Bubble Sci. Eng. Technol. 1:3–17, 2009.
Sirsi, S. R., and M. A. Borden. State-of-the-art materials for ultrasound-triggered drug delivery. Adv. Drug Deliv. Rev. 72:3–14, 2014.
Sirsi, S. R., C. Fung, S. Garg, M. Y. Tianning, P. A. Mountford, and M. A. Borden. Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery. Theranostics 3:409–419, 2013.
Skopec, M. M., A. E. Hagerman, and W. H. Karasov. Do salivary proline-rich proteins counteract dietary hydrolyzable tannin in laboratory rats? J. Chem. Ecol. 30:1679–1692, 2004.
Sorace, A. G., M. Korb, J. M. Warram, H. Umphrey, K. R. Zinn, E. Rosenthal, and K. Hoyt. Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer. Ultrasound Med. Biol. 40:755–764, 2014.
Sugatani, J., N. Fukazawa, K. Ujihara, K. Yoshinari, I. Abe, H. Noguchi, and M. Miwa. Tea polyphenols inhibit acetyl-CoA:1-alkyl-<i>sn</i>-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. Int. Arch. Allergy Immunol. 134:17–28, 2004.
Swart, A. M., S. Burdett, J. Ledermann, P. Mook, and M. K. Parmar. Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review. Ann. Oncol. 19:688–695, 2008.
Sweeting, M. J., S. G. Thompson, L. C. Brown, J. T. Powell, and R. collaborators. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br. J. Surg. 99:655–665, 2012.
Takagi, H., H. Manabe, N. Kawai, S. N. Goto, and T. Umemoto. Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis. Int. Angiol. 29:371–375, 2010.
Tam, H., W. Zhang, K. R. Feaver, N. Parchment, M. S. Sacks, and N. Vyavahare. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials. Biomaterials 66:83–91, 2015.
Tam, H., W. Zhang, D. Infante, N. Parchment, M. Sacks, and N. Vyavahare. Fixation of bovine pericardium-based tissue biomaterial with irreversible chemistry improves biochemical and biomechanical properties. J. Cardiovasc. Transl. Res. 10:194–205, 2017.
Tanios, F., M. W. Gee, J. Pelisek, S. Kehl, J. Biehler, V. Grabher-Meier, W. A. Wall, H. H. Eckstein, and C. Reeps. Interaction of biomechanics with extracellular matrix components in abdominal aortic aneurysm wall. Eur. J. Vasc. Endovasc. Surg. 50:167–174, 2015.
Tedder, M. E., J. Liao, B. Weed, C. Stabler, H. Zhang, A. Simionescu, and D. T. Simionescu. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng. A 15:1257–1268, 2009.
Tedder, M. E., A. Simionescu, J. Chen, J. Liao, and D. T. Simionescu. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng. A 17:25–36, 2011.
Thirugnanasambandam, M., D. Simionescu, G. P. Escobar, E. A. Sprague, B. Goins, G. Clarke, H. Han, K. Amezcua, O. Adeyinka, C. Goergen, and E. A. Finol. The effect of pentagalloyl glucose on the wall mechanics and inflammatory activity of rat abdominal aortic aneurysms. J. Biomech. Eng. 140:8, 2018.
Thomasset, S. C., D. P. Berry, G. Garcea, T. Marczylo, W. P. Steward, and A. J. Gescher. Dietary polyphenolic phytochemicals–promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer 120:451–458, 2007.
Thompson, R. W., and B. T. Baxter. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci 878:159–178, 1999.
Toda, M., J. Kawabata, and T. Kasai. Inhibitory effects of ellagi- and gallotannins on rat intestinal alpha-glucosidase complexes. Biosci. Biotechnol. Biochem. 65:542–547, 2001.
Torres-Leon, C., J. Ventura-Sobrevilla, L. Serna-Cock, J. A. Ascacio-Valdes, J. Contreras-Esquivel, and C. N. Aguilar. Pentagalloylglucose (PGG): a valuable phenolic compound with functional properties. J. Funct. Foods 37:176–189, 2017.
Tripi, D. R., and N. R. Vyavahare. Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves. J. Biomater. Appl. 28:757–766, 2014.
Tu, Z., W. Gong, Y. Zhang, Y. Feng, Y. Liu, and C. Tu. Inhibition of rabies virus by 1,2,3,4,6-penta-O-galloyl-beta-d-glucose involves mTOR-dependent autophagy. Viruses 10:201, 2018.
Vallianou, N. G., A. Kostantinou, M. Kougias, and C. Kazazis. Statins and cancer. Anti-cancer Agents Med. Chem. 14:706–712, 2014.
Venancio, V. P., H. Kim, M. A. Sirven, C. D. Tekwe, G. Honvoh, S. T. Talcott, and S. Mertens-Talcott. Polyphenol-rich Mango (Mangifera indica L.) Ameliorate Functional Constipation Symptoms in Humans beyond Equivalent Amount of Fiber. Mol. Nutr. Food Res. 62:1701034, 2018.
Vijaynagar, B., M. J. Bown, R. D. Sayers, and E. Choke. Potential role for anti-angiogenic therapy in abdominal aortic aneurysms. Eur. J. Clin. Invest. 43:758–765, 2013.
Villanueva, F. S., W. R. Wagner, M. A. Vannan, and J. Narula. Targeted ultrasound imaging using microbubbles. Cardiol. Clin. 22:283–298, 2004.
Viswanatha, G. L., H. Shylaja, and C. G. Mohan. Alleviation of transient global ischemia/reperfusion-induced brain injury in rats with 1,2,3,4,6-penta-O-galloyl-beta-d-glucopyranose isolated from Mangifera indica. Eur. J. Pharmacol. 720:286–293, 2013.
Vyavahare, N. R., Isenburg, J. C., Simionescu, D. T. Elastin stabilization of connective tissue. http://www.google.al/patents/US7252834. Google Patents, 2007.
Wang, X., A. Searle, Y. Chen, and K. Peter. Targeted microbubbles for the delivery of MicroRNA-126: treatment and prevention of abdominal aortic aneurysm. Heart Lung Circul. 26:S63, 2017.
Wang, G. W., J. Song, X. Tan, Y. Zhou, J. Chen, R. Li, L. Qiao, J. Song, C. Wang, and L. Zhang. Structural composition of components of geoherb Moutan Cortex contributes to anti-diabetic nephropathy activity. Oncotarget 2018. https://doi.org/10.18632/oncotarget.23771.
Wanhainen A. The efficacy of ticagrelor on abdominal aortic aneurysm expansion. https://clinicaltrials.gov/show/NCT02070653.
Westenburg, H. E., K. J. Lee, S. K. Lee, H. H. Fong, R. B. van Breemen, J. M. Pezzuto, and A. D. Kinghorn. Activity-guided isolation of antioxidative constituents of Cotinus coggygria. J. Nat. Prod. 63:1696–1698, 2000.
Whitlock, M. C., and W. G. Hundley. Noninvasive imaging of flow and vascular function in disease of the aorta. JACC Cardiovasc. Imaging 8:1094–1106, 2015.
Wolinsky, H., and S. Glagov. A lamellar unit of aortic medial structure and function in mammals. Circul. Res. 20:99–111, 1967.
Wroblewski, K., R. Muhandiram, A. Chakrabartty, and A. Bennick. The molecular interaction of human salivary histatins with polyphenolic compounds. Eur. J. Biochem. 268:4384–4397, 2001.
Wu, J., and X. Ding. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J. Agric. Food Chem. 49:501–506, 2001.
Xie, P., L. Cui, Y. Shan, and W. Y. Kang. antithrombotic effect and mechanism of radix paeoniae rubra. BioMed Res. Int. 2017:9475074, 2017.
Xiong, F. Y., Nirupama, S., Sirsi, S. R., Lacko, A., and Hoyt, K. Ultrasound-stimulated drug delivery of reconstituted high-density lipoprotein nanoparticles: Effects of drug concentration on tumor uptake. 2017 IEEE International Ultrasonics Symposium (Ius), pp. 1–4, 2017.
Xiong, J., Z. Wu, C. Chen, Y. Wei, and W. Guo. Association between diabetes and prevalence and growth rate of abdominal aortic aneurysms: a meta-analysis. Int. J. Cardiol. 221:484–495, 2016.
Yeo, Y., T. Ito, E. Bellas, C. B. Highley, R. Marini, and D. S. Kohane. In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions. Ann. Surg. 245:819–824, 2007.
Yrineo, A. A., A. R. Adelsperger, A. C. Durkes, M. R. Distasi, S. L. Voytik-Harbin, M. P. Murphy, and C. J. Goergen. Murine ultrasound-guided transabdominal para-aortic injections of self-assembling type I collagen oligomers. J. Control Release 249:53–62, 2017.
Yuan, B., and J. Rychak. Tumor functional and molecular imaging utilizing ultrasound and ultrasound-mediated optical techniques. Am. J. Pathol. 182:305–311, 2013.
Zhang, J., L. Li, S. H. Kim, A. E. Hagerman, and J Lu Anti-cancer. anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm. Res. 26:2066–2080, 2009.
Zhao, W., V. Haller, and A. Ritsch. The polyphenol PGG enhances expression of SR-BI and ABCA1 in J774 and THP-1 macrophages. Atherosclerosis 242:611–617, 2015.
Zou, L. Q., S. F. Peng, W. Liu, L. Gan, W. L. Liu, R. H. Liang, C. M. Liu, J. Niu, Y. L. Cao, Z. Liu, and X. Chen. Improved in vitro digestion stability of (-)-epigallocatechin gallate through nanoliposome encapsulation. Food Res. Int. 64:492–499, 2014.
Acknowledgments
The authors have no conflicts of interest to disclose and would like to acknowledge research funding from American Heart Association Award #16CSA28480006. The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Heart Association.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Jane Grande-Allen oversaw the review of this article.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Patnaik, S.S., Simionescu, D.T., Goergen, C.J. et al. Pentagalloyl Glucose and Its Functional Role in Vascular Health: Biomechanics and Drug-Delivery Characteristics. Ann Biomed Eng 47, 39–59 (2019). https://doi.org/10.1007/s10439-018-02145-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-018-02145-5